table of content
1 Prostate Cancer Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Therapeutics Drugs
1.2 Prostate Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Prostate Cancer Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Hormone Therapy
1.2.3 Chemotherapy
1.2.4 Biologic Therapy
1.2.5 Targeted Therapy
1.2.6 Other
1.3 Prostate Cancer Therapeutics Drugs Segment by Sale Channel
1.3.1 Global Prostate Cancer Therapeutics Drugs Sales Comparison by Sale Channel: (2022-2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.3.5 Other
1.4 Global Prostate Cancer Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Prostate Cancer Therapeutics Drugs Revenue 2017-2028
1.4.2 Global Prostate Cancer Therapeutics Drugs Sales 2017-2028
1.4.3 Prostate Cancer Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Prostate Cancer Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Prostate Cancer Therapeutics Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Prostate Cancer Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Prostate Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Prostate Cancer Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prostate Cancer Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Prostate Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostate Cancer Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Prostate Cancer Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Prostate Cancer Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Prostate Cancer Therapeutics Drugs Sales by Country
3.3.2 North America Prostate Cancer Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Prostate Cancer Therapeutics Drugs Sales by Country
3.4.2 Europe Prostate Cancer Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prostate Cancer Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Prostate Cancer Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Prostate Cancer Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Prostate Cancer Therapeutics Drugs Sales by Country
3.6.2 Latin America Prostate Cancer Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prostate Cancer Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Type (2017-2022)
4.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Prostate Cancer Therapeutics Drugs Price by Type (2017-2022)
5 Global Prostate Cancer Therapeutics Drugs Historic Market Analysis by Sale Channel
5.1 Global Prostate Cancer Therapeutics Drugs Sales Market Share by Sale Channel (2017-2022)
5.2 Global Prostate Cancer Therapeutics Drugs Revenue Market Share by Sale Channel (2017-2022)
5.3 Global Prostate Cancer Therapeutics Drugs Price by Sale Channel (2017-2022)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Corporation Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Amgen, Inc
6.4.1 Amgen, Inc Corporation Information
6.4.2 Amgen, Inc Description and Business Overview
6.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.4.5 Amgen, Inc Recent Developments/Updates
6.5 AbbVie, Inc
6.5.1 AbbVie, Inc Corporation Information
6.5.2 AbbVie, Inc Description and Business Overview
6.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Portfolio
6.5.5 AbbVie, Inc Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Corporation Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Ipsen Group
6.6.1 Ipsen Group Corporation Information
6.6.2 Ipsen Group Description and Business Overview
6.6.3 Ipsen Group Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ipsen Group Prostate Cancer Therapeutics Drugs Product Portfolio
6.7.5 Ipsen Group Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sanofi Prostate Cancer Therapeutics Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Endo Pharmaceuticals
6.9.1 Endo Pharmaceuticals Corporation Information
6.9.2 Endo Pharmaceuticals Description and Business Overview
6.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Portfolio
6.9.5 Endo Pharmaceuticals Recent Developments/Updates
6.10 Dendreon Corporation
6.10.1 Dendreon Corporation Corporation Information
6.10.2 Dendreon Corporation Description and Business Overview
6.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Portfolio
6.10.5 Dendreon Corporation Recent Developments/Updates
7 Prostate Cancer Therapeutics Drugs Manufacturing Cost Analysis
7.1 Prostate Cancer Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prostate Cancer Therapeutics Drugs
7.4 Prostate Cancer Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prostate Cancer Therapeutics Drugs Distributors List
8.3 Prostate Cancer Therapeutics Drugs Customers
9 Prostate Cancer Therapeutics Drugs Market Dynamics
9.1 Prostate Cancer Therapeutics Drugs Industry Trends
9.2 Prostate Cancer Therapeutics Drugs Market Drivers
9.3 Prostate Cancer Therapeutics Drugs Market Challenges
9.4 Prostate Cancer Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prostate Cancer Therapeutics Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Prostate Cancer Therapeutics Drugs by Type (2023-2028)
10.2 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Sale Channel
10.2.1 Global Forecasted Sales of Prostate Cancer Therapeutics Drugs by Sale Channel (2023-2028)
10.2.2 Global Forecasted Revenue of Prostate Cancer Therapeutics Drugs by Sale Channel (2023-2028)
10.3 Prostate Cancer Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prostate Cancer Therapeutics Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Prostate Cancer Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
